documents: FDA-2012-D-0307-0010
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-D-0307-0010 | FDA | FDA-2012-D-0307 | Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability | Notice | Notice of Availability | 2017-12-22T05:00:00Z | 2017 | 12 | 2017-12-22T05:00:00Z | 2018-03-23T03:59:59Z | 2018-01-06T02:01:16Z | 2017-27569 | 0 | 0 | 0900006482d56ac6 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref